Q&A: Panel Offers Actionable Steps Toward Hepatitis C Elimination
““It is rare to consider the elimination of any infectious disease,” Vincent Lo Re III, MD, MSCE, and colleagues noted in Clinical Infectious Diseases.”
US will let more people take methadone at home
“The first big update to U.S. methadone regulations in 20 years is poised to expand access to the life-saving drug starting next month, but experts say the addiction treatment changes could fall flat if state governments and methadone clinics fail to act.”
Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals
“Chronic hepatitis C virus (HCV) infection is associated with an increased risk of extrahepatic cancers, particularly non-Hodgkin lymphoma. The introduction of direct-acting antivirals (DAAs) has revolutionized HCV therapy, resulting in high cure rates. However, concerns have been raised about potential effects on cancer risk. This review summarizes the current evidence on extrahepatic cancer risk in HCV-infected patients treated with DAAs.”
Welcome to the INHSU Prisons Hepatitis C Advocacy Toolkit
“This toolkit provides guidance across three core areas that will support your advocacy efforts for the scale-up or implementation of prison-based hepatitis C testing, treatment and prevention services”
AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular Diagnostics – Technavio
“NEW YORK, Sept. 19, 2024 /PRNewswire/ — Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD 3.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.09% during the forecast period. Growing demand for molecular diagnostics in diagnosis of HBV and HCV is driving market growth, with a trend towards advent of immunosensors in HBV and HCV diagnostic tests. However, low penetration of HBV and HCV diagnostic tests poses a challenge.”
Renal Manifestations of Chronic Hepatitis C: A Review
“Hepatitis C virus (HCV) has emerged as a major global health concern and, if left untreated, can lead to significant liver damage, including cirrhosis, decompensated liver disease, and hepatocellular carcinoma (HCC). Approximately 40% of patients with HCV infection experience extrahepatic manifestations, including renal involvement. HCV-related renal disease is of significant importance among patients with chronic kidney disease (CKD), leading to higher morbidity and mortality.”
